Designing Your Clinical Trial for the Long Haul

Clinical trials have been traditionally designed with regulatory approval in mind, often overlooking key differences in goals between reimbursement (HTA) and regulatory agencies. Join us for a discussion on best practices for using HTA data to better inform trial design, and how this can save development time and help avoid negative decisions.